Top Markets
Coin of the day
Pharmanutra S.p.A. Pharmanutra S.p.A.

Pharmanutra S.p.A.

PHN
Pozycja w akcjach #9895
Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise,... Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.
Cena akcji
$97.03
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$929.06M
Zmiana (1 dzień)
-0.12%
Zmiana (1 rok)
70.33%
Kraj
IT
Handel Pharmanutra S.p.A. (PHN)

Kategoria

Historia ceny akcji dla Pharmanutra S.p.A. (PHN)
Najwyższa cena zamknięcia: $98.04 dnia 2026-08-01

Najniższa cena zamknięcia: $15.45 dnia 2017-07-01
Historia cen akcji firmy Pharmanutra S.p.A. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 25.47%
2025 11.38%
2024 -5.90%
2023 -8.56%
2022 -20.09%
2021 94.88%
2020 71.55%
2019 41.28%
2018 16.53%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN